Latin America Epilepsy Devices Market 2022-2028
MARKET OUTLOOK
Triton Market Research’s report suggests that the Latin America epilepsy devices market is expected to observe growth at a compound annual growth rate of 7.53% during the forecast years 2022-2028. Brazil, Mexico, and Rest of Latin America are assessed in the studied region.
In Mexico, epilepsy is among the major diseases that result in high mortality. Moreover, the rise in road traffic accidents has increased epilepsy seizures. In this regard, CT scans or MRI systems are majorly deployed to detect epilepsy nationwide. Furthermore, government initiatives and healthcare programs are creating awareness about epilepsy. Therefore, such steps are anticipated to open new avenues for the epilepsy devices market.
Furthermore, in Argentina, the market’s growth is supported by advances in diagnostic techniques. Moreover, knowledge of underlying pathophysiology has surged the efficacy of surgical procedures, thus increasing the patient pool for epilepsy surgery. For instance, refractory non-lesional focal epilepsy case operations have derived promising results. Hence, as stated above, these factors boost the epilepsy devices market’s development.
COMPETITIVE OUTLOOK
The key enterprises in the epilepsy devices market include Natus Medical Incorporated, LivaNova Plc, Medtronic Plc, Boston Scientific Corporation, and Neurosoft.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook